Iterum Therapeutics (NASDAQ: ITRM - Get Free Report) and Sol-Gel Technologies (NASDAQ: SLGL - Get Fr

Sol-Gel Technologies (NASDAQ: SLGL - Get Free Report)'s stock had its "buy" rating reiterated by equ

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Sol-Gel Technologies (NASDAQ:SLGL)

Trulieve Cannabis (NYSE: TRLV - Get Free Report) and Sol-Gel Technologies (NASDAQ: SLGL - Get Free R

UGP, SCSC, MRKR, SLGL and MEOH have been added to the Zacks Rank #1 (Strong Buy) List on October 16,

Sol-Gel Technologies NASDAQ: SLGL outlined its development and commercialization plans for SGT-610,

Sol-Gel Technologies Ltd. (SLGL) Analyst/Investor Day Transcript

Analysts initiated coverage on VYLR, IMTX, ENTG, SLGL and SPTX, assigning Neutral, Buy or Overweight

Cantor Fitzgerald analyst Imogen Mansfield initiates coverage on Sol-Gel Technologies (NASDAQ:SLG

SolGel Technologies (SLGL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism a

Shares of Sol-Gel Technologies Ltd. (NASDAQ: SLGL - Get Free Report) have been assigned a consensus

NESS ZIONA, Israel, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a

Sol-Gel Technologies (NASDAQ: SLGL - Get Free Report) and Heron Therapeutics (NASDAQ: HRTX - Get Fre

SolGel Technologies (SLGL) appears to have found support after losing some value lately, as indicate

Last patient has completed the last scheduled study visit in the pivotal Phase 3 clinical trial of S

Sol-Gel Technologies (NASDAQ:SLGL) reported quarterly losses of $(1.13) per share which beat the ana

NESS ZIONA, Israel, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a d

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Sol-Gel Technologies (NASDAQ:SLGL)

Wall Street analysts upgraded various top stocks, including Nucor, Varonis, Invitation Homes, and Ma

Wall Street analysts changed outlook on top names, see all changes on Benzinga's analyst ratings

Mizuho analyst Uy Ear initiates coverage on Sol-Gel Technologies (NASDAQ:SLGL) with a Outperform

Sol-Gel Technologies Ltd. (SLGL) came out with a quarterly loss of $1.31 per share versus the Zacks

Sol-Gel Technologies (NASDAQ:SLGL) reported quarterly losses of $(1.31) per share which beat the ana

Sol-Gel received a Notice of Allowance for a method-of-use patent extending intellectual property pr

NESS ZIONA, Israel, March 23, 2026 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (the “Company”) (NA

Sol-Gel Technologies Ltd. (SLGL) came out with a quarterly loss of $1.07 per share versus the Zacks

NESS ZIONA, Israel, March 19, 2026 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), an

Sol-Gel Technologies (NASDAQ: SLGL - Get Free Report) and Assembly Biosciences (NASDAQ: ASMB - Get F

Sol-Gel Technologies Ltd. (NASDAQ: SLGL - Get Free Report) major shareholder Opaleye Management Inc.

  On Thursday, 369 companies hit new 52-week lows.

  On Wednesday, 311 stocks hit new 52-week lows.

  On Tuesday, 647 companies set new 52-week lows.

  Friday's session saw 112 companies set new 52-week lows.

  During Thursday's session, 406 companies made new 52-week lows.

  On Tuesday, 386 stocks made new 52-week lows.

  Friday's session saw 169 companies set new 52-week lows.

Upgrades

Gainers United Maritime Corporation (NASDAQ: USEA) shares climbed 175.9% to close at $6.07 on Fr

  On Thursday, 588 stocks hit new 52-week lows.

  On Wednesday, 329 companies hit new 52-week lows.

  Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earning